USANA Health Sciences Files Q1 2025 10-Q
Ticker: USNA · Form: 10-Q · Filed: 2025-05-06T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, balance-sheet
TL;DR
USANA Health Sciences filed its Q1 2025 10-Q, showing updated financials. Check balance sheet for changes.
AI Summary
USANA Health Sciences Inc. filed its 10-Q for the period ending March 29, 2025. The filing provides financial data for the first quarter of 2025, comparing it to the same period in 2024. Key financial figures and balance sheet details are presented, including common stock, additional paid-in capital, retained earnings, and accumulated other comprehensive income as of March 30, 2024, and March 29, 2025.
Why It Matters
This filing provides investors with the latest financial performance and position of USANA Health Sciences, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2025-03-29 — End of Reporting Period (Financial data is reported as of this date.)
- 2024-03-30 — Prior Year Period End (Comparison point for Q1 2025 results.)
Key Players & Entities
- USANA HEALTH SCIENCES INC (company) — Filer
- 20250329 (date) — Period of Report
- 20250506 (date) — Filing Date
- SALT LAKE CITY (location) — Business Address City
- UT (location) — Business Address State
FAQ
What were the key changes in USANA's balance sheet from March 30, 2024, to March 29, 2025?
The filing details changes in 'Common Stock', 'Additional Paid-In Capital', 'Retained Earnings', and 'Accumulated Other Comprehensive Income' between these two dates.
What is the fiscal year end for USANA Health Sciences?
USANA Health Sciences' fiscal year ends on December 28.
In which state is USANA Health Sciences incorporated?
USANA Health Sciences is incorporated in Utah (UT).
What is the SEC file number for USANA Health Sciences?
The SEC file number for USANA Health Sciences is 001-35024.
What industry classification does USANA Health Sciences fall under?
USANA Health Sciences is classified under 'MEDICINAL CHEMICALS & BOTANICAL PRODUCTS' with SIC code [2833].
From the Filing
0000896264-25-000126.txt : 20250506 0000896264-25-000126.hdr.sgml : 20250506 20250506144226 ACCESSION NUMBER: 0000896264-25-000126 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20250329 FILED AS OF DATE: 20250506 DATE AS OF CHANGE: 20250506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 25916695 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 10-Q 1 usna-20250329.htm 10-Q usna-20250329 0000896264 12/28 2025 Q1 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares usna:segment xbrli:pure usna:region 0000896264 2024-12-29 2025-03-29 0000896264 2025-05-02 0000896264 2025-03-29 0000896264 2024-12-28 0000896264 2023-12-31 2024-03-30 0000896264 us-gaap:CommonStockMember 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-30 0000896264 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-31 2024-03-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 2024-03-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 2024-03-30 0000896264 us-gaap:CommonStockMember 2023-12-31 2024-03-30 0000896264 us-gaap:CommonStockMember 2024-03-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-03-30 0000896264 us-gaap:RetainedEarningsMember 2024-03-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-30 0000896264 2024-03-30 0000896264 us-gaap:CommonStockMember 2024-12-28 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-12-28 0000896264 us-gaap:RetainedEarningsMember 2024-12-28 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-28 0000896264 us-gaap:RetainedEarningsMember 2024-12-29 2025-03-29 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-29 2025-03-29 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-12-29 2025-03-29 0000896264 us-gaap:CommonStockMember 2024-12-29 2025-03-29 0000896264 us-gaap:CommonStockMember 2025-03-29 0000896264 us-gaap:AdditionalPaidInCapitalMember 2025-03-29 0000896264 us-gaap:RetainedEarningsMember 2025-03-29 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-29 0000896264 usna:HiyaMember 2024-12-23 0000896264 usna:HiyaMember 2024-12-23 2024-12-23 0000896264 usna:HiyaMember 2023-12-31 2024-03-30 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-29 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-29 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-29 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-29 0000896264 us-gaap:FairValueMeasurementsRecurringMember 2025-03-29 0000896264 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-29 0000896264 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-29 0000896264 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-29 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-28 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLeve